Literature DB >> 8832985

Systemic lupus erythematosus: predictors of its occurrence among a cohort of patients with early undifferentiated connective tissue disease: multivariate analyses and identification of risk factors.

J Calvo-Alen1, G S Alarcon, S L Burgard, N Burst, A A Bartolucci, H J Williams.   

Abstract

OBJECTIVE: To determine predictors of the occurrence of systemic lupus erythematosus (SLE) in patients with early (< or = 1 yr) undifferentiated connective tissue disease (CTD).
METHODS: Analysis of a cohort of 213 patients with early undifferentiated CTD at entry, followed for 5 yrs at 11 tertiary centers. Baseline demographic, clinical, and laboratory data were compared using univariate and Cox multivariate regression analyses to identify possible predictive features for the subsequent occurrence of SLE.
RESULTS: 143 of 213 patients had ascertainable clinical status at 5 yrs. By univariate analyses those who evolved to SLE (13%) were more likely to be younger, African-American, and to have alopecia, serositis, discoid lupus, positive Coombs' test, positive anti-dsDNA and anti-Sm antibodies, positive ANA (homogeneous pattern), and/or a false positive test for syphilis. Discoid lupus (relative risk = 15.8), serositis (4.1), ANA-homogeneous (4.8), and anti-Sm positivity (28.2) were retained as predictors of the occurrence of SLE in the Cox regression model.
CONCLUSION: Some clinical and laboratory features in patients with early undifferentiated CTD can predict the subsequent occurrence of SLE.

Entities:  

Mesh:

Year:  1996        PMID: 8832985

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  15 in total

1.  Development of SLE among "potential SLE" patients seen in consultation: long-term follow-up.

Authors:  M Al Daabil; E M Massarotti; A Fine; H Tsao; P Ho; P H Schur; B L Bermas; K H Costenbader
Journal:  Int J Clin Pract       Date:  2014-05-23       Impact factor: 2.503

Review 2.  Preclinical systemic lupus erythematosus.

Authors:  Julie M Robertson; Judith A James
Journal:  Rheum Dis Clin North Am       Date:  2014-09-02       Impact factor: 2.670

3.  We need better classification and terminology for "people at high risk of or in the process of developing lupus".

Authors:  Karen H Costenbader; Peter H Schur
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-05       Impact factor: 4.794

4.  Screening characteristics for enrichment of individuals at higher risk for transitioning to classified SLE.

Authors:  K A Young; M E Munroe; J M Guthridge; D L Kamen; G S Gilkensen; J B Harley; M H Weisman; D R Karp; D J Wallace; J A James; J M Norris
Journal:  Lupus       Date:  2019-03-07       Impact factor: 2.911

5.  Undifferentiated connective tissue disease in a rheumatology center in Cali, Colombia: clinical features of 94 patients followed for a year.

Authors:  Luis F Guerrero; Juan C Rueda; Raquel Arciniegas; Jorge M Rueda
Journal:  Rheumatol Int       Date:  2011-11-25       Impact factor: 2.631

Review 6.  Diagnostic criteria for systemic lupus erythematosus: has the time come?

Authors:  George K Bertsias; Cristina Pamfil; Antonios Fanouriakis; Dimitrios T Boumpas
Journal:  Nat Rev Rheumatol       Date:  2013-07-09       Impact factor: 20.543

Review 7.  Differentiating between UCTD and early-stage SLE: from definitions to clinical approach.

Authors:  Savino Sciascia; Dario Roccatello; Massimo Radin; Ioannis Parodis; Jinoos Yazdany; Guillermo Pons-Estel; Marta Mosca
Journal:  Nat Rev Rheumatol       Date:  2021-11-11       Impact factor: 20.543

Review 8.  Understanding the Concept of Pre-Clinical Autoimmunity: Prediction and Prevention of Systemic Lupus Erythematosus: Identifying Risk Factors and Developing Strategies Against Disease Development.

Authors:  May Y Choi; Karen H Costenbader
Journal:  Front Immunol       Date:  2022-06-03       Impact factor: 8.786

9.  Undifferentiated connective tissue disease: a seven-center cross-sectional study of 184 patients.

Authors:  C C Vaz; M Couto; D Medeiros; L Miranda; J Costa; P Nero; R Barros; M J Santos; E Sousa; A Barcelos; L Inês
Journal:  Clin Rheumatol       Date:  2009-04-24       Impact factor: 2.980

10.  Autoantibody-Positive Healthy Individuals Display Unique Immune Profiles That May Regulate Autoimmunity.

Authors:  Samantha Slight-Webb; Rufei Lu; Lauren L Ritterhouse; Melissa E Munroe; Holden T Maecker; Charles G Fathman; Paul J Utz; Joan T Merrill; Joel M Guthridge; Judith A James
Journal:  Arthritis Rheumatol       Date:  2016-10       Impact factor: 10.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.